Cspc Pharmaceutical | 1093 - Fremdkapital

Aktienkurs
8.23
Täglich Wechseln
-0.26 -3.06%
Monatlich
-16.87%
Jährlich
67.28%
Q1 Prognose
8.60




Fremdkapital Veränderung Datum
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Cspc Pharmaceutical CNY 158.75M 102.62M 2025-06
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Jiangsu Hengrui CNY 43.31M 8.11M 2025-12
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Moderna USD 610M 584M 2025-12
Organon & Co USD 8.78B 117M 2025-09
Revvity USD 2.63B 543K 2025-12
Sh Fosun Pharma CNY 15.39B 1.34B 2025-12
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.48B 7M 2025-12
Wuxi Apptec CNY 2.27B 475.26M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09